Latest NewsSep 25, 2025HiFiBiO Therapeutics to Present Updated Phase 1 Clinical Data of Two Immuno-Oncology Programs at the 2025 Annual Meeting of the European Society for Medical Oncology (ESMO) All Filter By: Year20252024202320222021202020192018201720162015Apr 12, 2021Clinical approach and biomarker strategy for HFB301001, a novel OX40 agonistic antibodyApr 12, 2021HFB9-2, a novel Galectin 9 neutralizing antibody for the treatment of AML and other cancersApr 12, 2021Mechanism of Action and Biomarker Strategy for HFB200301, an Anti-TNFR2 Agonist Antibody for the Treatment of CancerApr 12, 2021Discovery and characterization of a novel anti-human CXCR5 antibody for the treatment of B cell lymphomasApr 6, 2021HiFiBiO Therapeutics to Present Progress on Four Novel Immunotherapy Programs at AACR 2021< 1 … 7 8 9 10 11 … 18 >
